APR 28, 2017 06:00 AM PDT

Disseminated Intravascular Coagulation (DIC) and Thrombosis: The Critical Role of the Lab

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Scientific Business Development Manager, Diagnostica Stago, Inc.
    Biography
      Paul earned a PhD in biochemistry from Temple University in 2006, with the subject of the dissertation regarding the function of coagulation factor XI. He also did postdoctoral training in a related area before becoming a product manager and scientific affairs specialist in 2009. During his time at Stago, Paul also completed an MBA degree program at Cornell University in 2014. He has spoken to dozens of medical technologist, clinical laboratory scientist, pharmacist and clinician audiences about various topics within hemostasis and coagulation. He also has a great interest in working with clinical pathologists, pharmacists, basic scientists, and pharmaceutical researchers to perform studies and publish, contributing to advancement of the hemostasis and coagulation science.

    Abstract:

    Disseminated Intravascular Coagulation (DIC) is a serious hypercoagulable disorder which can occur in hospitalized patients resulting in a high degree of morbidity and mortality.  DIC is a confusing disorder from both diagnostic and therapeutic standpoints resulting from several unrelated diseases which can trigger DIC, along with a lack of uniformity in clinical manifestation, laboratory diagnostic practices, and consensus on patient management.  The laboratory, by implementing the correct panel of testing methodologies, can greatly assist clinicians in patient management.  This lecture will describe the laboratory testing in order to illuminate this condition for people unfamiliar with the condition.

    Learning objectives:

    1. Describe the basic pathophysiology of DIC
    2. Demonstrate a diagnostic and management approach for DIC
    3. Compare markers of thrombin & plasmin generation in DIC, including D-Dimer, Fibrin Monomers/soluble fibrin, and fibrin degradation products (FDPs)
    4. Correlate DIC theory and testing to specific clinical case

     


    Show Resources
    You May Also Like
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    JUN 20, 2018 10:00 AM EDT
    C.E. CREDITS
    JUN 20, 2018 10:00 AM EDT
    DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    Loading Comments...